Synopsis
Synopsis
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector


1. 5 Formyltetrahydrofolate
2. 5 Formyltetrahydropteroylglutamate
3. 5-formyltetrahydrofolate
4. 5-formyltetrahydropteroylglutamate
5. Acid, Folinic
6. Calcium Folinate
7. Citrovorum Factor
8. Factor, Citrovorum
9. Folinate, Calcium
10. Folinic Acid
11. Folinic Acid Sf
12. Folinic Acid-sf
13. Leucovorin
14. Leucovorin, (d)-isomer
15. Leucovorin, (dl)-isomer
16. Leucovorin, (r)-isomer
17. Leucovorin, Calcium
18. Leucovorin, Calcium (1:1) Salt
19. Leucovorin, Calcium (1:1) Salt, (dl)-isomer
20. Leucovorin, Calcium (1:1) Salt, Pentahydrate
21. Leucovorin, Monosodium Salt
22. Leukovorin
23. Leukovorum
24. Monosodium Salt Leucovorin
25. N(5)-formyltetrahydrofolate
26. Wellcovorin
1. Calcium Folinate
2. Calcium Citrovorum Factor
3. Folinic Acid Calcium Salt
4. Folinic Acid-sf, Calcium Salt
5. (+)-l-folinic Acid, Calcium Salt
6. 1492-18-8
7. Nsc3590
8. Sr-05000001662
9. Pharmakon1600-01500364
10. Nsc757083
11. Nsc-757083
12. Sr-05000001662-1
13. Sr-05000001662-2
14. Glutamic Acid,6,7,8-tetrahydro-4-hydroxy-6- Pteridinyl)methyl]amino]benzoyl]-, Calcium Salt (1:1), L-
15. L-glutamic Acid,4,5,6,7,8-hexahydro-4-oxo-6- Pteridinyl)methyl]amino]benzoyl]-, Calcium Salt (1:1), (s)-
| Molecular Weight | 513.5 g/mol |
|---|---|
| Molecular Formula | C20H23CaN7O7+2 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 513.1284869 g/mol |
| Monoisotopic Mass | 513.1284869 g/mol |
| Topological Polar Surface Area | 216 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 2 |
| Complexity | 911 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antidotes
Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)
Vitamin B Complex
A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)
V - Various
V03 - All other therapeutic products
V03A - All other therapeutic products
V03AF - Detoxifying agents for antineoplastic treatment
V03AF03 - Calcium folinate
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
41
PharmaCompass offers a list of Calcium Folinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Calcium Folinate manufacturer or Calcium Folinate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcium Folinate manufacturer or Calcium Folinate supplier.
A Factor, Citrovorum manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Factor, Citrovorum, including repackagers and relabelers. The FDA regulates Factor, Citrovorum manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Factor, Citrovorum API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Factor, Citrovorum manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Factor, Citrovorum supplier is an individual or a company that provides Factor, Citrovorum active pharmaceutical ingredient (API) or Factor, Citrovorum finished formulations upon request. The Factor, Citrovorum suppliers may include Factor, Citrovorum API manufacturers, exporters, distributors and traders.
click here to find a list of Factor, Citrovorum suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Factor, Citrovorum DMF (Drug Master File) is a document detailing the whole manufacturing process of Factor, Citrovorum active pharmaceutical ingredient (API) in detail. Different forms of Factor, Citrovorum DMFs exist exist since differing nations have different regulations, such as Factor, Citrovorum USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Factor, Citrovorum DMF submitted to regulatory agencies in the US is known as a USDMF. Factor, Citrovorum USDMF includes data on Factor, Citrovorum's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Factor, Citrovorum USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Factor, Citrovorum suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Factor, Citrovorum Drug Master File in Japan (Factor, Citrovorum JDMF) empowers Factor, Citrovorum API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Factor, Citrovorum JDMF during the approval evaluation for pharmaceutical products. At the time of Factor, Citrovorum JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Factor, Citrovorum suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Factor, Citrovorum Drug Master File in Korea (Factor, Citrovorum KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Factor, Citrovorum. The MFDS reviews the Factor, Citrovorum KDMF as part of the drug registration process and uses the information provided in the Factor, Citrovorum KDMF to evaluate the safety and efficacy of the drug.
After submitting a Factor, Citrovorum KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Factor, Citrovorum API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Factor, Citrovorum suppliers with KDMF on PharmaCompass.
A Factor, Citrovorum CEP of the European Pharmacopoeia monograph is often referred to as a Factor, Citrovorum Certificate of Suitability (COS). The purpose of a Factor, Citrovorum CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Factor, Citrovorum EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Factor, Citrovorum to their clients by showing that a Factor, Citrovorum CEP has been issued for it. The manufacturer submits a Factor, Citrovorum CEP (COS) as part of the market authorization procedure, and it takes on the role of a Factor, Citrovorum CEP holder for the record. Additionally, the data presented in the Factor, Citrovorum CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Factor, Citrovorum DMF.
A Factor, Citrovorum CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Factor, Citrovorum CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Factor, Citrovorum suppliers with CEP (COS) on PharmaCompass.
A Factor, Citrovorum written confirmation (Factor, Citrovorum WC) is an official document issued by a regulatory agency to a Factor, Citrovorum manufacturer, verifying that the manufacturing facility of a Factor, Citrovorum active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Factor, Citrovorum APIs or Factor, Citrovorum finished pharmaceutical products to another nation, regulatory agencies frequently require a Factor, Citrovorum WC (written confirmation) as part of the regulatory process.
click here to find a list of Factor, Citrovorum suppliers with Written Confirmation (WC) on PharmaCompass.
Factor, Citrovorum Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Factor, Citrovorum GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Factor, Citrovorum GMP manufacturer or Factor, Citrovorum GMP API supplier for your needs.
A Factor, Citrovorum CoA (Certificate of Analysis) is a formal document that attests to Factor, Citrovorum's compliance with Factor, Citrovorum specifications and serves as a tool for batch-level quality control.
Factor, Citrovorum CoA mostly includes findings from lab analyses of a specific batch. For each Factor, Citrovorum CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Factor, Citrovorum may be tested according to a variety of international standards, such as European Pharmacopoeia (Factor, Citrovorum EP), Factor, Citrovorum JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Factor, Citrovorum USP).